U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07600320) titled 'Fareon Open Label Device Clinical Trial' on May 14.
Brief Summary: The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Cognitive Dysfunction
Acquired Brain Injury
Traumatic Brain Injury
Intervention:
DEVICE...